subject area of
- Genetic Risk Evaluation in Wet Age-Related Macular Degeneration Treatment Response Academic Article
- Genetic Risk Factors Are Not Associated with Wet Age-Related Macular Degeneration Treatment Response to Ranibizumab Academic Article
- Ozurdex in age-related macular degeneration as adjunct to ranibizumab (The OARA Study) Academic Article
- Pharmacologic management of neovascular age-related macular degeneration: systematic review of economic evidence and primary economic evaluation Academic Article
- Ranibizumab and the eye Academic Article
- Ranibizumab vs. aflibercept for wet age-related macular degeneration: network meta-analysis to understand the value of reduced frequency dosing Academic Article